Protective Effect of Neuropeptide Substance P on Bone Marrow Mesenchymal Stem Cells against Apoptosis Induced by Serum Deprivation

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Fu, Su ^a   Jin, Dan ^a   Liu, Song ^a   Wang, Lei ^a   Wang, Zhao ^b   Mei, Gang ^c   Zou, Zhen Lv ^a   Wu, Jian Qun ^a   Xu, Zi Yi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Xiangyang Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 9; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MYC PROTEIN; NEUROKININ 1 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; SUBSTANCE P; WNT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL NUCLEUS; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; STEM CELL CULTURE;

EID: 84935832425     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/270328     Document Type: Article

References (36)

1. D. B. Mach, S. D. Rogers, M. C. Sabino et al., "Origins of skeletal pain: Sensory and sympathetic innervation of themouse femur," Neuroscience, vol. 113, no. 1, pp. 155-166, 2002.
2. D. Liu, H. Li, C.-Q. Zhao, L.-S. Jiang, and L.-Y. Dai, "Changes of substance P-immunoreactive nerve fiber innervation density in the sublesional bones in young growing rats at an early stage after spinal cord injury," Osteoporosis International, vol. 19, no. 4, pp. 559-569, 2008.
3. M. A. Adamus and Z. J. Dabrowski, "Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro," Journal of Cellular Biochemistry, vol. 81, no. 3, pp. 499-506, 2001.
4. S.-Y. Chen, J.-J. Qin, L. Wang et al., "Different effects of implanting vascular bundles and sensory nerve tracts on the expression of neuropeptide receptors in tissue-engineered bone in vivo," Biomedical Materials, vol. 5, no. 5, Article ID 55002, 2010.
5. L. Wang, H. Fan, Z.-Y. Zhang et al., "Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized β-tricalcium phosphate scaffold and mesenchymal stem cells," Biomaterials, vol. 31, no. 36, pp. 9452-9461, 2010.
6. L. Wang, R. Zhao, X. Shi et al., "Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro," Bone, vol. 45, no. 2, pp. 309-320, 2009.
7. H.-B. Sun, J.-C. Chen, Q. Liu, M.-F. Guo, and H.-P. Zhang, "Substance P stimulates differentiation of mice osteoblast through up-regulating Osterix expression," Chinese Journal of Traumatology, vol. 13, no. 1, pp. 46-50, 2010.
8. C. Shih and G. W. Bernard, "Neurogenic substance P stimulates osteogenesis in vitro," Peptides, vol. 18, no. 2, pp. 323-326, 1997.
9. H.-W. Koon, D. Zhao, Y. Zhan, M. P. Moyer, and C. Pothoulakis, "Substance P mediates antiapoptotic responses in human colonocytes by Akt activation," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 6, pp. 2013-2018, 2007.
10. Y. S. An, E. Lee, M.-H. Kang et al., "Substance P stimulates the recovery of bone marrow after the irradiation," Journal of Cellular Physiology, vol. 226, no. 5, pp. 1204-1213, 2011.
11. V. Krishnan, H. U. Bryant, and O. A. MacDougald, "Regulation of bone mass byWnt signaling," Journal of Clinical Investigation, vol. 116, no. 5, pp. 1202-1209, 2006.
12. R. Baron and G. Rawadi, "Targeting theWnt/β-catenin pathway to regulate bone formation in the adult skeleton," Endocrinology, vol. 148, no. 6, pp. 2635-2643, 2007.
13. P. Babij, W. Zhao, C. Small et al., "High bone mass in mice expressing a mutant LRP5 gene," Journal of Bone and Mineral Research, vol. 18, no. 6, pp. 960-974, 2003.
14. M. Kato, M. S. Patel, R. Levasseur et al., "Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, aWnt coreceptor,"The Journal of Cell Biology, vol. 157, no. 2, pp. 303-314, 2002.
15. B. T. MacDonald, K. Tamai, and X. He, "Wnt/beta-catenin signaling: components, mechanisms, and diseases," Developmental Cell, vol. 17, no. 1, pp. 9-26, 2009.
16. G. Mei, L. Xia, J. Zhou et al., "Neuropeptide SP activates the WNT signal transduction pathway and enhances the proliferation of bone marrow stromal stem cells," Cell Biology International, vol. 37, no. 11, pp. 1225-1232, 2013.
17. M. Almeida, L. Han, T. Bellido, S. C. Manolagas, and S. Kousteni, "Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblast by β-catenin-dependent and-independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT," Journal of Biological Chemistry, vol. 280, no. 50, pp. 41342-41351, 2005.
18. P. V. N. Bodine, "Wnt signaling control of bone cell apoptosis," Cell Research, vol. 18, no. 2, pp. 248-253, 2008.
19. J. J. Cao, P. A. Singleton, S. Majumdar et al., "Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44," Journal of Bone and Mineral Research, vol. 20, no. 1, pp. 30-40, 2005.
20. J. E. Chipuk, J. C. Fisher, C. P. Dillon, R. W. Kriwacki, T. Kuwana, and D. R. Green, "Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 51, pp. 20327-20332, 2008.
21. Z. N. Oltvai, C. L. Milliman, and S. J. Korsmeyer, "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death," Cell, vol. 74, no. 4, pp. 609-619, 1993.
22. R. D. Ramnath, J. Sun, S. Adhikari, and M. Bhatia, "Effect of mitogen-activated protein kinases on chemokine synthesis induced by substance P in mouse pancreatic acinar cells," Journal of Cellular and Molecular Medicine, vol. 11, no. 6, pp. 1326-1341, 2007.
23. N. Sharon, I. Mor, T. Golan-Lev, A. Fainsod, and N. Benvenisty, "Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells," Stem Cells, vol. 29, no. 4, pp. 600-608, 2011.
24. E. Mrak, F. Guidobono, G. Moro, G. Fraschini, A. Rubinacci, and I. Villa, "Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by β-catenin stabilization," Journal of Cellular Physiology, vol. 225, no. 3, pp. 701-708, 2010.
25. H. S. Hong, J. Lee, E. Lee et al., "Anew role of substance P as an injury-inducible messenger for mobilization of CD29+ stromallike cells," Nature Medicine, vol. 15, no. 4, pp. 425-435, 2009.
26. M.-H. Kang, D.-Y. Kim, J. Y. Yi, and Y. Son, "Substance P accelerates intestinal tissue regeneration after γ-irradiationinduced damage," Wound Repair and Regeneration, vol. 17, no. 2, pp. 216-223, 2009.
27. Q.-H. Liang, Y. Liu, S.-S. Wu, R.-R. Cui, L.-Q. Yuan, and E.-Y. Liao, "Ghrelin inhibits the apoptosis ofMC3T3-E1 cells through ERK and AKT signaling pathway," Toxicology and Applied Pharmacology, vol. 272, no. 3, pp. 591-597, 2013.
28. X. Zeng, S. P. Yu, T. Taylor, M. Ogle, and L. Wei, "Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis," StemCell Research, vol. 8, no. 3, pp. 357-367, 2012.
29. T. Arai, N. Yoshimi, H. Fujiwara, and K. Sekizawa, "Serum substance P concentrations and silent aspiration in elderly patients with stroke," Neurology, vol. 61, no. 11, pp. 1625-1626, 2003.
30. M. Matucci-Cerinic, A. Lombardi, G. Leoncini et al., "Neutral endopeptidase (3. 4. 24. 11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?" Rheumatology International, vol. 13, no. 1, pp. 1-4, 1993.
31. O. Grimsholm, S. Rantapaa-Dahlqvist, and S. Forsgren, "Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis," Arthritis Research and Therapy, vol. 7, pp. R416-R426, 2005.
32. T. Rosse, R. Olivier, L. Monney et al., "Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c," Nature, vol. 391, no. 6666, pp. 496-499, 1998.
33. R. M. Kluck, E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer, "The release of cytochrome c frommitochondria: a primary site for Bcl-2 regulation of apoptosis," Science, vol. 275, no. 5303, pp. 1132-1136, 1997.
34. G. Mei, Z. Zou, S. Fu et al., "Substance P activates the wnt signal transduction pathway and enhances the differentiation of mouse preosteoblasticMC3T3-E1 cells," International Journal of Molecular Sciences, vol. 15, no. 4, pp. 6224-6240, 2014.
35. S. Fu, G. Mei, Z. Wang et al., "Neuropeptide substance P improves osteoblastic and angiogenic differentiation capacity of bone marrow stem cells in vitro," BioMed Research International, vol. 2014, Article ID 596023, 10 pages, 2014.
36. Y. Tuo, X. Guo, X. Zhang et al., "The biological effects and mechanisms of calcitonin gene-related peptide on human endothelial cell," Journal of Receptors and Signal Transduction, vol. 33, no. 2, pp. 114-123, 2013.